Highlights

- Net income during the third quarter of 2026 increased $387 thousand, or 14.7%, to $3.0 million, or $0.85 per diluted share, from $2.6 million, or $0.74 per diluted share, in the 2025 period. Adjusting for ongoing merger charges increased net income to $3.3 million, or $0.94 per diluted share.

- Return on average assets and equity improved to 1.12% and 10.15%, respectively, in the third quarter of 2026 compared to 1.05% and 9.60%, respectively, in the third quarter of 2025. Adjusting for ongoing merger charges improved return on average assets and equity to 1.24% and 11.23%, respectively.

- Net interest income increased $945 thousand, or 10.7%, to $9.8 million in the third quarter of 2026 from $8.9 million in the third quarter of 2025.

- Net interest margin was 3.83% in the third quarter of 2026 compared to 3.73% in the third quarter of 2025.

- Yield on loans held for investment improved to 6.28% for the third quarter of 2026 compared to 6.11% in the third quarter of 2025.

- Loans held for investment increased $6.2 million, or 0.8%, to $744.9 million at September 30, 2026 from $738.7 million at December 31, 2025, and increased $12.0 million, or 1.6%, from $732.9 million at September 30, 2025. During the third quarter of 2026, loans held for investment increased $14.7 million, or 2.0%, from $730.2 million at June 30, 2026.

- The ratio of loans held for investment-to-deposits increased to 78.4% at September 30, 2026 from 76.0% at December 31, 2025.

- Allowance for credit losses as of September 30, 2026, was 1.16% of loans held for investment compared to 1.18% as of June 30, 2026 and 1.40% as of December 31, 2025.

- Tangible book value per common share increased to $31.68 at September 30, 2026 from $30.26 at December 31, 2025 and $29.44 at September 30, 2025.

BISMARCK, N.D., Oct. 30, 2026 /PRNewswire/ -- BNCCORP, INC. (BNC or the Company) (OTCQX Markets: BNCC), which operates community banking and wealth management businesses in North Dakota and Arizona, today reported financial results for the third quarter ended September 30, 2026.

Management Commentary

"Our third quarter results reflect the continued strength of our core banking franchise," said Daniel J. Collins, BNC's President and Chief Executive Officer. "Net income increased 14.7% from the third quarter of 2025. Net interest income grew 10.7% year-over-year, and our net interest margin of 3.83% was 10 basis points higher than a year ago and essentially unchanged from the second quarter, as higher loan yields and lower deposit costs more than offset lower yields on cash and securities.

"Loans held for investment grew $14.7 million, or 2.0%, and deposits increased $37.7 million during the quarter. We were pleased to see loan growth in the quarter despite an elevated level of payoffs and prepayments in an environment of rising costs and higher interest rates. Our asset quality remains sound and our capital ratios remain well above regulatory requirements.

"The proposed combination with OppFi, announced on April 29, 2026, is proceeding through the customary shareholder and regulatory processes. Our priorities during this period have not changed: serving our customers, supporting our communities and operating the bank with the discipline that produced this quarter's results. We remain confident in the overall quality of our loan portfolio, the strength of our balance sheet and our ability to navigate ongoing economic and geopolitical uncertainties."

2026 Versus 2025 Third Quarter Comparison

The Company reported net income of $3.0 million, or $0.85 per diluted share, for the third quarter of 2026 compared to $2.6 million, or $0.74 per diluted share, in the third quarter of 2025. Excluding the impact of expenses associated with the merger transaction, the Company reported net income of $3.3 million, or $0.94 per diluted share.

Interest income increased $783 thousand, or 5.9%, to $14.1 million in the third quarter of 2026 from $13.4 million in the third quarter of 2025 driven by higher loan yields, a $4.1 million period-over-period increase in the average balance of loans held for investment and higher average balances of cash and cash equivalents. Those increases were partially offset by lower yields on cash and cash equivalents and a lower average balance of debt securities during the quarter. Average yield on interest-earning assets in the quarter decreased slightly to 5.51% from 5.62% in the third quarter of 2025.

Interest expense in the third quarter of 2026 was $4.3 million, a decrease of $162 thousand from the 2025 period. The cost of core deposits in the third quarter of 2026 decreased to 1.75% versus 1.94% in the third quarter of 2025. The average balance of deposits increased by $60.7 million compared to the third quarter of 2025. The cost of interest-bearing liabilities was 2.24% during the third quarter of 2026, compared to 2.49% in the same period of 2025.

Net interest income for the third quarter of 2026 was $9.8 million, an increase of $945 thousand, or 10.7%, from the third quarter of 2025. Net interest margin increased to 3.83% in the third quarter of 2026 compared to 3.73% reported in the prior year period.

Non-interest income during the third quarter of 2026 was $1.6 million, compared to $1.4 million in the 2025 third quarter. Bank charges and service fees were $16 thousand lower period-over-period primarily due to lower overdraft fees and letter of credit fees partially offset by higher interchange income. Wealth management revenues increased by $113 thousand, or 21.2%, over the prior year period as the Company has benefitted from the addition of new assets under administration and increases in the market value of financial assets year-over-year. Other income was $96 thousand higher than the prior year period as a result of valuation adjustments on deferred compensation, gains on sale of assets and higher SBIC revenue.

Non-interest expense during the third quarter of 2026 increased $743 thousand, or 11.2%, year-over-year, primarily due to a $495 thousand increase in professional services as the Company incurred $461 thousand of expenses in connection with the previously announced agreement to be acquired by OppFi Inc. Data processing fees increased $101 thousand. Inflationary factors over core banking services, card processing charges and higher IT subscriptions drove the largest increases. Occupancy expense increased $52 thousand primarily due to increased building repair and maintenance charges.

In the third quarter of 2026, income tax expense was $902 thousand, compared to $809 thousand in the third quarter of 2025. The Company's effective tax rate was 23.0% and 23.5% for the third quarter of 2026 and 2025, respectively.

Tangible book value per common share on September 30, 2026 was $31.68 compared to $30.26 at December 31, 2025. The Company's tangible common equity capital ratio increased to 10.30% as of September 30, 2026, compared to 9.68% on December 31, 2025.

2026 Versus 2025 First Nine Months Comparison

The Company reported net income of $7.1 million, or $2.00 per diluted share, for the first nine months of 2026 compared to $6.6 million, or $1.86 per diluted share, in the first nine months of 2025. Excluding the impact of expenses associated with the merger transaction, the Company reported net income of $8.9 million, or $2.52 per diluted share.

Interest income increased $3.7 million, or 9.8%, to $41.6 million in the first nine months of 2026 from $37.9 million in the first nine months of 2025 driven by a $20.4 million period-over-period increase in the average balance of loans held for investment and higher balances of cash and cash equivalents. Those increases were partially offset by lower yields on cash and cash equivalents and a lower average balance and yields on debt securities during the current period. Average yield on interest-earning assets in the first nine months of 2026 was 5.47%, compared to 5.51% in the first nine months of 2025.

Interest expense in the first nine months of 2026 was $13.1 million, an increase of $391 thousand from the 2025 period. The cost of core deposits in the first nine months of 2026 decreased to 1.79% versus 1.89% in the first nine months of 2025. The average balance of deposits increased by $84.0 million compared to the first nine months of 2025. The cost of interest-bearing liabilities was 2.27% during the first nine months of 2026, compared to 2.44% in the same period of 2025.

Net interest income for the first nine months of 2026 was $28.5 million, an increase of $3.3 million, or 13.2%, from the first nine months of 2025. Net interest margin was 3.75% in the 2026 nine-month period compared to 3.66% reported in the prior year period.

Non-interest income in the first nine months of 2026 was $4.5 million compared to $4.2 million in the 2025 first nine months. Bank charges and service fees were $42 thousand higher period-over-period primarily due to higher servicing income, interchange income, and letter of credit fees that were partially offset by lower non-use fees on lines of credit and a reduction in deposits held in one-way sell positions. Wealth management revenues increased by $267 thousand, or 17.3%, as the Company has benefited from the addition of new assets under administration and increases in the market value of financial assets year-over-year. Other income was higher than the prior year due to valuation adjustments on deferred compensation and higher SBIC and BOLI revenue that was partially offset by lower gains on sale of assets.

Non-interest expense during the first nine months of 2026 increased $2.9 million, or 14.2%, year-over-year, primarily due to a $2.7 million increase in professional services expense as the Company has incurred expenses primarily related to the previously announced agreement to be acquired by OppFi Inc. The Company also reported an increase of $289 thousand in data processing fees.

POLYTECH Health & Aesthetics and London Regenerative Institute Partner to Advance Adipose Tissue Processing in Aesthetic and Reconstructive Surgery

DIEBURG, Germany and LONDON, Oct. 30, 2026 /PRNewswire/ -- POLYTECH Health & Aesthetics, a global leader in breast aesthetics, reconstruction, and body contouring with a presence in more than 90 countries, and the London Regenerative Institute (LRI), a clinician-led institute specializing in regenerative medicine, adipose tissue processing and translational education, today announced a worldwide partnership to advance the use of adipose tissue-based techniques in aesthetic and reconstructive surgery.

Fat grafting and adipose tissue-based approaches are increasingly being integrated into aesthetic and reconstructive procedures beyond traditional volume restoration, including refinement procedures and applications focused on tissue quality and regeneration. As a result, these techniques are gaining importance across both surgical and office-based settings.

The partnership brings together two complementary capabilities. POLYTECH contributes an established international commercial infrastructure, long-standing relationships with plastic and reconstructive surgeons, and a training model focused on hands-on education. The London Regenerative Institute contributes a clinician-led research and development environment with a focus on adipose tissue processing, regenerative protocols and structured clinical training.

LRI has developed an integrated ecosystem around adipose tissue applications, including LipoCube and related technologies for different levels of tissue processing. These range from standard fat grafting to more refined approaches such as micro- and nanofat preparation and biologically oriented adjuncts. In parallel, the institute has established training programs and workshops aimed at translating these techniques into routine clinical use.

"Fat grafting and adipose tissue-based procedures are becoming an increasingly important part of modern aesthetic and reconstructive surgery," said Prof. Dr. Karsten Hemmrich, CEO of POLYTECH Health & Aesthetics. "Through the partnership with LRI, we are combining scientific expertise, clinical education and global commercial reach to support surgeons with structured and reproducible approaches in this evolving field."

"One of the major challenges in regenerative surgery is the standardization of tissue processing and clinical workflows," said Prof. Dr. Tunç Tiryaki, Founder of the London Regenerative Institute. "Our work has focused on translating regenerative concepts into practical protocols supported by education and physician training. Together with POLYTECH, we now have the opportunity to make these approaches more accessible."

A central element of the partnership will be the implementation of training-based programs, including workshops, physician education and procedure-oriented guidance. Such formats have been shown to play a key role in the adoption of fat grafting techniques, where outcomes depend not only on the technology used, but also on the consistency of preparation and application.

The partnership involves launching a portfolio, as well as physician education initiatives, workshops, and clinical training programs. Additional details regarding market rollout, training activities, and product availability will be shared in accordance with local regulatory requirement.

About POLYTECH Health & Aesthetics

Celebrating its 40th anniversary in 2026, POLYTECH Health & Aesthetics combines "Quality Made in Germany" with scientific expertise, precision manufacturing, and continuous innovation in breast aesthetics, reconstruction, and body contouring. The company supports surgeons and patients worldwide in more than 90 countries through procedure-oriented solutions, education initiatives, and clinical partnership that advance aesthetic and reconstructive surgery, including technologies such as B-Lite®, the world's first lightweight breast implant technology.

About the London Regenerative Institute (LRI)

The London Regenerative Institute (LRI) is a UK-based institute specializing in regenerative medicine, longevity, and adipose tissue-based therapies for aesthetic and reconstructive applications. Bringing together clinicians, researchers, and biotechnology expertise, LRI focuses on advancing regenerative approaches through clinical innovation, translational research, physician education, and the development of science-based therapeutic solutions. The institute combines clinical practice, translational research and physician education to support the development and adoption of regenerative treatment concepts.

SOURCE POLYTECH Health & Aesthetics GmbH

Share this article

Veröffentlichungstermine des Statistischen Bundesamtes (DESTATIS) vom 02.11.2026 bis 06.11.2026

Wiesbaden (ots)

Veröffentlichungstermine des Statistischen Bundesamtes (DESTATIS) - die Veröffentlichung erfolgt in der Regel 08:00 Uhr:

Montag, 02.11.2026

- (Nr. N074) Zum Weltmännertag am 03.11.2026: Verkehrsunfälle von Männern und Frauen, Jahr 2025

- (Nr. 383) Umsatz im Einzelhandel, September 2026

Dienstag, 03.11.2026

- (Nr. N075) Produktion von zuckerhaltigen und Light-Erfrischungsgetränken sowie Adipositas im internationalen Vergleich, Jahre 2019-2025

- (Nr. 45) Zahl der Woche: Produktion von Nahrungsergänzungsmitteln, Jahr 2025

Mittwoch, 04.11.2026

- (Nr. 384) Schülerinnen und Schüler, Einschulungen, Lehrkräfte und Abschlüsse an allgemeinbildenden und beruflichen Schulen (endg. Ergebnisse), Schuljahr 2025/2026

- (Nr. N076) Anteil von Führungskräften in der EU sowie Verdienste von Führungskräften in Deutschland, April/Jahr 2025

Donnerstag, 05.11.2026

- (Nr. 385) Verarbeitendes Gewerbe (Auftragseingang und Umsatz), September 2026

- (Nr. 386) Entwicklung der privaten Haushalte bis zum Jahr 2050

- (Nr. 387) Umsatz im Dienstleistungsbereich, August 2026

- (Nr. 388) Arbeitskostenerhebung, Jahr 2024

Freitag, 06.11.2026

- (Nr. 389) Produktionsindex, September 2026

(Nr.###) = Voraussichtliche Meldungsnummerierung.

Die Veröffentlichungstermine sowie weitere Informationen sind im Internetangebot des Statistischen Bundesamtes zu finden unter: https://www.destatis.de/DE/Presse/Termine/Veroeffentlichungstabelle/_inhalt.html

Verbreitung mit Quellenangabe erwünscht.

Herausgeber:

DESTATIS | Statistisches Bundesamt

Gustav-Stresemann-Ring 11

65189 Wiesbaden

Pressekontakt:

Statistisches Bundesamt

Pressestelle

www.destatis.de/kontakt

Telefon: +49 611-75 34 44

Original-Content von: Statistisches Bundesamt, übermittelt durch news aktuell

Bruttoinlandsprodukt im 3. Quartal 2026 um 0,2 % höher als im Vorquartal

Wirtschaftsleistung in Deutschland nimmt erneut zu

WIESBADEN (ots)

Bruttoinlandsprodukt (BIP), 3. Quartal 2026

+0,2 % zum Vorquartal (preis-, saison- und kalenderbereinigt)

+1,3 % zum Vorjahresquartal (preisbereinigt)

+1,2 % zum Vorjahresquartal (preis- und kalenderbereinigt)

Das Bruttoinlandsprodukt (BIP) ist im 3. Quartal 2026 gegenüber dem 2. Quartal 2026 - preis-, saison- und kalenderbereinigt - um 0,2 % gestiegen, nachdem es bereits in der ersten Jahreshälfte 2026 gewachsen war. Wie das Statistische Bundesamt (Destatis) weiter mitteilt, entwickelten sich die Konsumausgaben preis-, saison- und kalenderbereinigt gegenüber dem Vorquartal leicht positiv. Dagegen gingen die Investitionen laut den vorläufigen Erkenntnissen zurück. Die in der ersten Jahreshälfte noch sehr dynamische Entwicklung der Exporte schwächte sich im 3. Quartal 2026 merklich ab.

Bruttoinlandsprodukt im Vorjahresvergleich gestiegen

Im Vorjahresvergleich lag das BIP im 3. Quartal 2026 preisbereinigt um 1,3 % höher als im 3. Quartal 2025. Preis- und kalenderbereinigt betrug der Anstieg 1,2 %.

Revision der bisherigen Ergebnisse

Neben der Erstberechnung des 3. Quartals 2026 hat das Statistische Bundesamt wie üblich auch die bisher veröffentlichten Ergebnisse der Vorquartale überarbeitet und neu verfügbare statistische Informationen in die Berechnungen des 1. und 2. Quartals 2026 einbezogen. Dabei ergaben sich für das vierteljährliche preisbereinigte BIP keine Änderungen der bisherigen Ergebnisse.

Methodische Hinweise:

In allen Meldungen zu Konjunkturindikatoren sind die unterschiedlichen Vergleichszeiträume zu beachten. Im Fokus der Konjunkturbeobachtung steht der Vergleich der saison- und kalenderbereinigten Werte zum Vormonat/Vorquartal. Hieraus lässt sich die kurzfristige konjunkturelle Entwicklung ablesen. Der Vorjahresvergleich dient einem längerfristigen Niveauvergleich und ist von saisonalen Schwankungen weitgehend unabhängig.

Weitere Informationen:

Ausführliche Ergebnisse für das 3. Quartal 2026 gibt das Statistische Bundesamt am 25. November 2026 bekannt.

Eine lange Reihe mit Quartalsergebnissen zum Bruttoinlandsprodukt seit dem 1. Quartal 1970 ist im Statistischen Bericht "Volkswirtschaftliche Gesamtrechnungen" verfügbar.

Das BIP ist auch im "Dashboard Konjunktur" (www.dashboard-konjunktur.de) verfügbar. In diesem Datenportal bündelt das Statistische Bundesamt hochfrequente Indikatoren der amtlichen Statistik und weiterer Datenanbieter zu den Themen Wirtschaft und Finanzen sowie Arbeitsmarkt, Bauen und Energie.

Diese Pressemitteilung ist, gegebenenfalls ergänzt mit weiteren Informationen und Verlinkungen zum Thema, veröffentlicht unter www.destatis.de/pressemitteilungen.

Weitere Auskünfte:

VGR-Infoteam

Telefon: +49 611 75 2626

www.destatis.de/kontakt

Pressekontakt:

Statistisches Bundesamt

Pressestelle

www.destatis.de/kontakt

Telefon: +49 611-75 34 44

Original-Content von: Statistisches Bundesamt, übermittelt durch news aktuell

Murmeln, Mond und Ahle Wurscht: Tobi Kämmerer entdeckt Kassel neu

Frankfurt am Main/Kassel (ots)

Deutscher Meister im Murmeln werden, mit einer Hörspiellegende auf Zeitreise gehen, Pink Floyd unter Sternen erleben und Käsefondue mit nordhessischer Note genießen: In einer neuen Folge von "Tobis Städtetrip", die am Dienstag, 3. November, um 20.15 Uhr im hr-fernsehen gezeigt wird, erkundet hr3-Moderator Tobi Kämmerer erneut Kassel und begegnet außergewöhnlichen Menschen und überraschenden Geschichten.

Am Auedamm trifft Tobi Rainer Schielke-Funke und Johannes Funke vom KSV Auedamm. Die beiden gehörten 2025 zum Kasseler Team, das die Deutsche Murmelmeisterschaft gewann. Sie zeigen, warum Murmeln weit mehr als ein Kinderspiel ist - und ob Tobi selbst Meisterqualitäten besitzt.

Im HÖR.SPIEL-Museum im Palais Bellevue begegnet er Heikedine Körting. Als Produzentin von Klassikern wie "Die drei ???", "TKKG" und "Hanni und Nanni" prägte sie Generationen. Im Körting-Kabinett sind Erinnerungsstücke ihrer jahrzehntelangen Arbeit zu sehen. Tobi darf selbst ans Mikrofon und ein eigenes kleines Hörspiel produzieren.

Im Planetarium in der Orangerie, Hessens größtem Planetarium, geht es zu Sternen und Galaxien. Bei einem Pink-Floyd-Musikprogramm verschmelzen die Songs der britischen Rockband unter der zehn Meter großen Kuppel mit dem projizierten Nachthimmel. Im Matterhorn-Stübli bereitet Tobi mit Küchenchef Yves Käsefondue zu - mit Bier und Ahler Wurscht als nordhessischer Variante des Schweizer Klassikers. Im Bergpark Wilhelmshöhe erwecken Marius Kowalczyk und Iris Bohm von der Rokoko-Gesellschaft "Plaisir de la Campagne" die Freizeitkultur des 18. Jahrhunderts zum Leben. Zwischen Picknick und historischen Spielen wagt sich Tobi an eine Runde "Blinde Kuh".

Action gibt es schließlich im "Levels" am Holländischen Platz: Auf rund 1.200 Quadratmetern warten mehr als 70 Arcade-Automaten mit Rennsimulationen, Basketball-, Tanz- und Reaktionsspielen. Von der Murmelmeisterschaft bis ins Weltall, vom Rokoko bis zur Spielhalle: "Tobis Städtetrip" zeigt Kassel von überraschenden Seiten - und beweist, dass selbst für Kenner der Stadt noch Neues zu entdecken ist.

Pressekontakt:

Pressereferent

Christian Bender

Tel.: 069 155 2290

E-Mail: christian.bender@hr.de

HERAUSGEBER

Hessischer Rundfunk

Kommunikation

Tel.: 069 155 3500

E-Mail: kommunikation@hr.de

Original-Content von: HR Hessischer Rundfunk, übermittelt durch news aktuell

Train as we fight: die 10. Panzerdivision übt in Litauen

2 Dokumente

- 261030_PM_ENG_Übungen10.PzDivinLitauen_FINAL.pdf

PDF - 372 kB

- 261030_PM_Übungen10.PzDivinLitauen_FINAL.pdf

PDF - 378 kB

Veitshöchheim, 30.10.2026 (ots)

Unter Führung der 10. Panzerdivision üben Anfang November Kräfte der beiden schweren, gepanzerten Brigaden in Litauen. Vor Ort finden zwei Übungen zeitgleich statt: die Übung "Freedom Shield 26-II" der Panzerbrigade 45 auf dem Truppenübungsplatz in Rudninkai und die Übung "Grand Eagle 26" der Panzergrenadierbrigade 37 auf dem Truppenübungsplatz Pabrade. Die 10. Panzerdivision stellt die Führung der Brigaden während der Übungen in Litauen sowie aus dem Heimatstandort im bayerischen Veitshöchheim heraus sicher - von der Alarmierung bis zur Rückkehr aller Truppenteile an ihre Heimatstandorte.Insgesamt nehmen mehr als 6.000 Soldatinnen und Soldaten der Division an den Übungen teil. "Unser Ziel als Warfighting Division, die im Ernstfall vom Multinational Corps Northeast in Stettin geführt wird, ist das ganzheitliche Erlangen von Siegfähigkeit. Dafür üben wir mit unseren Brigaden vor Ort in Litauen denn: Es gibt keinen zweiten Sieger im Krieg.," sagt Generalmajor Jörg See, Kommandeur der 10. Panzerdivision.

Pressekontakt:

10. PANZERDIVISION

Oberdürrbacher Straße

97209 Veitshöchheim

Tel. +49 (0) 931 9707 - 3160

Original-Content von: PIZ Heer, übermittelt durch news aktuell

WELT zu US-Midterm-Wahlen mit 32 Stunden Sonderprogramm, Chefredakteur Fuhst live in Washington, Augmented-Reality-Grafiken im Studio

Berlin (ots)

Mit einer rund 32-stündigen Live-Sonderprogrammierung im Umfeld der US-Midterm-Wahlen am 3. und 4. November 2026, einem eigenen Korrespondenten-Aufgebot in den Vereinigten Staaten und Talk-Runden vorm Capitol begleitet der Nachrichtensender WELT die richtungsweisenden Kongress- und Gouverneurswahlen in den USA.

In der Wahlnacht und am Folgetag ordnen unter anderem die ehemaligen deutschen US-Botschafter Wolfgang Ischinger und Emily Haber, Spitzenpolitiker wie Armin Laschet (CD), Norbert Röttgen (CD), Marie-Agnes Strack-Zimmermann (FDP), Omid Nouripour (GRÜNE), Anton Hofreiter (GRÜNE) und Jürgen Hardt (CDU) sowie die Sicherheitsexperten Carlo Masala und Nico Lange die Ergebnisse und ihre Folgen für Deutschland und Europa ein.

WELT-Chefredakteur Helge Fuhst wird dabei live aus Washington, D.C. berichten: Vom eigenen WELT-Set unmittelbar am Capitol sendet Fuhst von 00:00 Uhr bis 06:00 Uhr (deutscher Zeit) Talk-Runden mit US-Insidern, darunter US-Journalist Erik Kirschbaum und Politikwissenschaftlerin Gerlinde Groitl.

Das technische Highlight der WELT-Sondersendung ist die innovative Wahlanalyse mit Augmented-Reality-Grafiken (AR) durch Marian Grunden: Mithilfe von AR-Modellen wird Grunden im Studio das US-Capitol virtuell "aufklappen", um die Mehrheitsverhältnisse in Senat und Repräsentantenhaus, die entscheidenden Bundesstaaten sowie die wichtigsten Gouverneursduelle plastisch zu erklären. In der Wahlnacht steht ein Analyse-Touchscreen im Wahlstudio, an dem Grunden die Echtzeit-Daten von den engsten Kopf-an-Kopf-Rennen über aktuelle Auszählungsstände bis zu den Endergebnissen auswertet. Im Berliner Wahlstudio begleiten Politikberater Julius van de Laar und Stormy-Annika Mildner (Direktorin Aspen Institute Deutschland) als Dauergäste die Wahlnacht.

Bereits im Vorfeld der Wahl startete das neue achtteilige Analyse-Format "DEEPDIVE AMERICA", in dem Marian Grunden gemeinsam mit Politikberater und Kampagnen-Experte Julius van de Laar am Touchscreen die spannendsten Trends rund um die Midterms seziert.

Das Wahl-Sonderprogramm von WELT im Überblick:

- Vorab: Achtteiliges Format "DEEPDIVE AMERICA" mit Marian Grunden und Julius van de Laar im TV, auf YouTube und Instagram;

- Dienstag, 03. November, 06:00 bis 21:15 Uhr: Durchgehende Live-Berichterstattung zum Wahltag in den USA mit Reporter-Schalten in die entscheidenden Bundesstaaten (im Anschluss: "WELT-Reporter Spezial");

- 23:45 bis 06:00 Uhr: "Wahl-Sondersendung" zur US-Wahlnacht mit Marie Droste und Carsten Hädler in der Moderation, Live-Datenanalyse von Marian Grunden, Dauergäste Julius van de Laar sowie Stormy-Annika Mildner; Live-Talks direkt vom Capitol in Washington, D.C. mit WELT-Chefredakteur Helge Fuhst, Dauergast Erik Kirschbaum und weiteren Experten;

- Mittwoch, 04. November, 06:00 bis 14:30 Uhr: Der Tag nach der US-Wahl mit Tatjana Ohm und Thomas Klug in der Moderation, Analysen von Marco Reinke aus dem Newsroom sowie Reaktionen aus Washington und Berlin;

- bis 22:00 Uhr: Spezial-Sendungen im Tagesverlauf u. a. mit Wolfgang Ischinger, Norbert Röttgen, Anton Hofreiter, Marie-Agnes Strack-Zimmermann, Emily Haber, Omid Nouripour, Carlo Masala, Jürgen Hardt und Gabor Steingart.

"DEEPDIVE AMERICA" - Alle Episoden auf YouTube: https://www.youtube.com/watch?v=9Kc-NaEHDm4&list=PLH5picEjLx2Y (Playlist)

Pressekontakt:

Kritsanarat Khunkham

Director Communications PREMIUM-GRUPPE

kritsanarat.khunkham@axelspringer.com

030 2591 77608

Original-Content von: WELT, übermittelt durch news aktuell

HPP Awareness Day 2026: Neuer Patientenfilm gibt Menschen mit Hypophosphatasie eine Stimme

Drei Geschichten. Drei Kontinente. Eine seltene Erkrankung.

- Video-Infos

- Download

- Ein weiterer Medieninhalt

München (ots)

"Man sieht es mir nicht an. Aber die Erkrankung begleitet mich jeden Tag."

Mit diesen Worten beschreibt Antje ihr Leben mit Hypophosphatasie (HPP), einer seltenen erblichen Systemerkrankung, die sich unter anderem auf Muskeln und Gelenke, Knochen und Zähne auswirken kann. "Ich habe einen sehr langen Leidensweg hinter mir", fährt sie fort, "die Schmerzen, die ich habe, sind oft schrecklich. Und lange konnte mir niemand sagen, wo der Ursprung dieser Schmerzen liegt." Wie Antje geht es vielen Patient:innen mit dieser Erkrankung. HPP kann den Alltag stark einschränken, z. B. durch chronische Schmerzen, Fatigue und Muskelschwäche. [1] Da die Beschwerden unspezifisch sind und auch bei anderen Erkrankungen auftreten können, ist es für Ärzt:innen oft schwierig, sie richtig einzuordnen. Mitunter werden sie daher zunächst anderen Erkrankungen zugeschrieben. [2] Erschwerend kommt hinzu, dass HPP selten und daher im medizinischen Alltag weniger präsent ist. [3]

In einem internationalen Patientenfilm, der anlässlich des HPP Awareness Day veröffentlicht wird, erzählen Antje aus Deutschland, Mario aus Brasilien und Lisa aus den USA ihre Geschichten. Sie berichten von der gemeinsamen Realität vieler HPP-Betroffener: jahrelange Beschwerden, Unsicherheit, fehlende Gewissheit und ein oft langer Weg zur Diagnose. Dabei zeigen sie, wie HPP das soziale Leben, die Familie und die Zukunftspläne beeinflussen kann - und welche Erleichterung die richtige Diagnose für sie bedeutet hat.

HPP - eine Erkrankung mit vielen Gesichtern

Seltene Erkrankungen wie Hypophosphatasie werden häufig erst spät erkannt. Für die Betroffenen und ihre Familien kann das mit erheblichen Belastungen verbunden sein. "Deshalb ist es wichtig, ihre Erfahrungen sichtbar zu machen und das Bewusstsein für die Erkrankung zu stärken", sagt Michael Burkart, 1. Vorsitzender des HPP Deutschland e. V. Jede persönliche Geschichte, die erzählt wird, kann dazu beitragen, Verständnis zu schaffen und anderen Betroffenen Orientierung und Zuversicht zu geben.

Hypophosphatasie wird durch eine erblich bedingte verminderte Aktivität des Enzyms alkalische Phosphatase verursacht. [1] Da dieses Enzym bei vielen Vorgängen im Körper eine Rolle spielt, kann sich die Erkrankung sehr unterschiedlich und in jedem Alter äußern. Die Beschwerden reichen von Muskel- und Gelenkschmerzen, Fatigue und Mobilitätseinschränkungen bis hin zu wiederholten Frakturen.[1,4,5] Je nach Ausprägung kann HPP die körperliche Belastbarkeit und Selbstständigkeit daher stark einschränken. [6] Die Belastung ist dabei nicht immer direkt sichtbar. "Leuten zu erklären, dass man einfach müde und erschöpft ist und keine Kraft hat, ist schwierig, weil man es nicht sieht - anders als beispielsweise bei einem gebrochenen Bein mit Gips - und viele Menschen es deshalb nicht verstehen", erzählt Antje.

Die vielfältigen und oft unspezifischen Beschwerden können denen rheumatischer Erkrankungen, einer Osteoporose oder einer Fibromyalgie ähneln und dadurch die Diagnose erschweren. [1,4] Ein wiederholter Nachweis einer zu niedrigen Aktivität der alkalischen Phosphatase im Blut kann einen wichtigen Hinweis auf HPP geben und sollte ärztlich abgeklärt werden. [4]

Mehr Aufmerksamkeit für HPP

Seit 2020 engagieren sich Alexion und die Patientenorganisation HPP Deutschland e. V. gemeinsam, um über die Erkrankung aufzuklären und die Bedürfnisse von Menschen mit HPP stärker ins öffentliche Bewusstsein zu rücken. Der neue Patientenfilm bildet den Mittelpunkt der diesjährigen Awareness-Aktivitäten. Er lädt dazu ein, zuzuhören, hinzusehen und die Perspektive derjenigen kennenzulernen und zu verstehen, die mit HPP leben.

Film ansehen und mehr erfahren

Den kompletten Film sowie weiterführende Informationen zu Hypophosphatasie finden Interessierte unter: https://ots.de/eCawBX

Alexion

Alexion, AstraZeneca Rare Disease, ist der Unternehmensbereich von AstraZeneca, der auf seltene Krankheiten spezialisiert ist und 2021 durch die Übernahme von Alexion Pharmaceuticals, Inc. entstand. Alexion ist seit über 30 Jahren führend auf dem Gebiet der seltenen Erkrankungen und hat das Ziel, Patient:innen und Familien, die von schwerwiegenden seltenen Erkrankungen betroffen sind, durch die Entdeckung, Entwicklung und Verbreitung von lebensverändernden Medikamenten zu helfen. Alexion konzentriert seine Forschungsaktivitäten auf neuartige Moleküle und Zielmoleküle in der Komplementkaskade und seine Entwicklungsaktivitäten auf die Bereiche Hämatologie, Nephrologie, Neurologie, Stoffwechselstörungen, Kardiologie und Ophthalmologie. Mehr unter www.alexion.de.

AstraZeneca

Die AstraZeneca GmbH ist die deutsche Tochtergesellschaft des britisch-schwedischen Pharmaunternehmens AstraZeneca PLC. AstraZeneca (LSE/STO/Nasdaq: AZN) ist ein globales, wissenschaftsorientiertes biopharmazeutisches Unternehmen, das sich auf die Erforschung, Entwicklung und Vermarktung von verschreibungspflichtigen Medikamenten in den Bereichen Onkologie, seltene Krankheiten und Biopharmazeutika, einschließlich Herz- Kreislauf, Nieren und Stoffwechsel sowie Atemwege und Immunologie, konzentriert. AstraZeneca mit Sitz in Cambridge, Großbritannien, ist in über 100 Ländern tätig. Die innovativen Medikamente des Unternehmens werden von Millionen von Patient:innen weltweit eingesetzt. Weitere Informationen auf www.astrazeneca.de.

Referenzen:

1 Seefried L et al., Calcif Tissue Int. 2025; 116(1):46.

2 Jetter EM, Lucke-Wold BP, World J Clin Cases. 2025; 13(31):109020.

3 Högler W et al., BMC Musculoskelet Disord. 2019; 20:80.

4 Khan AA et al., Osteoporos Int. 2024; 35(3):431-438.

5 Jakob F, Diagnostik und Management der Hypophosphatasie. UNI-MED, 2. Auflage 2021.

6 Seefried L et al., J Bone Miner Res. 2020; 35(11):2171-217

DE-103915/10-26

Pressekontakt:

Alexion Kontakt

Stephanie Ralle-Zentgraf

Director, Communications Germany

Alexion Pharma Germany GmbH

MOBILE +49 160 99560808

E-MAIL stephanie.ralle-zentgraf@alexion.com

Original-Content von: Alexion Pharma Germany GmbH, übermittelt durch news aktuell

"The Pet Variable" Launches as National Coalition to Address Barriers to Health, Housing and Financial Security for Families with Pets

Led by experts across public health, human healthcare, veterinary medicine, social services and policy, The Pet Variable seeks to build healthier families and stronger communities by making the human-animal bond part of how we understand and support well-being

SAN ANTONIO, Oct. 30, 2026 /PRNewswire/ -- Today, national public health experts, veterinarians, researchers and advocates launched The Pet Variable, a new coalition working to make the human-animal bond an enduring part of public health and policy. For millions of Americans, caring for a pet is deeply connected to caring for themselves. The Pet Variable will work across health, housing, financial security, and other systems to advance policies and practices that address barriers to keeping people and pets together and protect families' health, safety, and stability. You can read more about The Pet Variable here: thepetvariable.com.

The coalition launches alongside a new policy proposal put forward by the non-profit AlignCare Health and published in the Journal of One Health Systems, highlighting how barriers to maintaining the human-animal bond can prevent families with pets from accessing healthcare, securing stable housing or protecting their personal safety. When up to 70% of American families include a pet, the paper makes the case for formally recognizing the human-animal bond as a social determinant of health (SDoH) and outlines opportunities for policymakers to incorporate it into future federal, state and local public health frameworks.

"When someone delays their health care because they are worried about what will happen to their pet, struggles to find stable or temporary housing that accommodates their pet, or faces financial strain trying to meet both human and veterinary needs, those aren't separate challenges. They are interconnected," said Anna Stout, MA, CAWA, Executive Director of the Pet Variable. "The Pet Variable coalition was created to advance policies and systems that recognize that connection and support the health and stability of the whole family."

The Pet Variable has nine founding members spanning public health, veterinary medicine, housing, social services, research and policy: CARE (Companions and Animals for Reform and Equity), Annie & Millie's Place, RedRover, BestyBnB, My Dog is My Home, Massachusetts Society for the Prevention of Cruelty to Animals (MSPCA), Ohio State's College of Veterinary Medicine, JVR Strategies, and The Pet Vet Connection.

"At BestyBnB, we've seen how something as simple as providing temporary care for a pet can make all the difference in helping someone access the support they need," said Andy Bond, Co-Founder of BestyBnB. "Our work has shown us that solutions are possible when human services and animal care work together, and these connections need to become the norm rather than the exception. We're proud to be a Founding Member of The Pet Variable and help bring these practical, community-based solutions into broader conversations about public policy and how we care for families."

The Pet Variable will be inaugurated in person at the 2026 One Health Systems Summit in San Antonio on October 31, where public health, veterinary, housing, social services and policy experts will examine how existing systems affect families with pets. The Summit will feature discussions on gaps in current laws, policies and funding; barriers to integrated human and veterinary care; and models for better coordinating workforces, governance and funding across sectors.

New Research Examines the Human-Animal Bond Across Systems

Released alongside The Pet Variable's launch, the new policy proposal, "Recognizing the Human-Animal Bond as a Social Determinant of Health," published in the Journal of One Health Systems (JOHS), examines the growing body of evidence showing how pets can affect human health and well-being, and how barriers involving pets can influence families' access to health care, housing and safety. The proposal makes the case for formally recognizing the human-animal bond as a social determinant of health and highlights key research including:

- Health care: 61.5% of healthcare providers surveyed reported encountering a patient at least once per month who delayed treatment because of pet-related concerns. Pet-related concerns can also influence where patients seek treatment or cause them to leave care early.

- Housing: While 50% of landlords allow pets, only 9% do so without size or species restrictions. Meanwhile, 27% of respondents in another study said the cost of a pet deposit itself created a barrier.

- Domestic violence: Research has found that 18% to 48% of domestic violence survivors delayed leaving an abusive situation out of concern for their pet, while just 18% of domestic violence shelters accept pets nationally.

- Health and economic benefits: Research cited in the paper estimates that pet ownership generated $11.8 billion in U.S. healthcare cost savings from reduced doctor visits and decreased obesity in 2015 alone.

The Journal of One Health Systems was recently launched as a peer-reviewed, open access journal committed to advancing health equity for families that include pets. The journal is building a new body of research on the institutional and systemic factors that shape the health and well-being of people, animals, and the communities they share. That evidence will serve as a resource for healthcare leaders and policymakers and can inform efforts such as The Pet Variable's policy goals. Researchers and practitioners across disciplines are invited to submit manuscripts presenting new studies, evidence, and models here.

Local, State and Federal Policy Push

Across the country, state and local policymakers are increasingly taking action to address barriers facing pet families, from expanding pet-inclusive housing and access to veterinary care to helping people remain with their pets when seeking shelter from homelessness or domestic violence. Earlier this year, Colorado enacted legislation recognizing the human-animal bond as a social determinant of health. At the same time, policymakers in states including Massachusetts and Arizona, as well as New York City, have advanced efforts aimed at reducing barriers facing pet families, particularly in housing.

The Pet Variable will build on this momentum by bringing together experts across sectors to identify policy gaps, elevate models that are working and advance greater recognition of the human-animal bond at the agency, local, state and federal levels.

At the federal level, the coalition will advocate for recognition of the human-animal bond as a social determinant of health within Healthy People 2040, while supporting opportunities across healthcare access, housing, healthy aging, behavioral health, survivor safety, homelessness, veterinary access and other areas where the human-animal bond can have meaningful implications for human health and well-being.

"For too long, policies affecting people and their pets have been developed in separate conversations, even though the challenges pet families face are deeply interconnected," said Jamie Blackburn, Housing Policy Specialist at the MSPCA. "Through our advocacy work in Massachusetts, we've seen how even small, local policy changes can make a meaningful difference for people and their animals. The Pet Variable offers an opportunity to build on that progress, bringing new voices and perspectives into the conversation and making the human-animal bond part of how we approach public policy nationwide."

About The Pet Variable

The Pet Variable is a national coalition working to support healthier families by making the human-animal bond an enduring part of how we think about well-being and shape health policy. Bringing together leaders across public health, healthcare, housing, social services, veterinary medicine, research and other fields, the coalition works to break down policy silos, address pet-related barriers to health, housing and stability, and build greater recognition of the human-animal bond within state and national health policy frameworks. Learn more at thepetvariable.com.

Media Contact: Tiffany Garcia, [email protected]

SOURCE The Pet Variable

Share this article

HONG KONG, Oct. 30, 2026 /PRNewswire/ -- CNOOC Limited (the "Company" or "CNOOC Limited", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announced its operating results for the third quarter of 2026. The Company continued to increase its reserves and production and steadily advanced exploration and development projects, achieving continued growth in net production of oil and gas and net profit attributable to equity shareholders.

In the first three quarters, the Company achieved a net production of 593.7 million barrels of oil equivalent ("BOE"), an increase of 2.7% year-on-year ("YoY"), hitting a historic high for the same period. Net production from China reached 408.5 million BOE, an increase of 1.9% YoY, which was mainly attributable to the production contribution from projects including Kenli 10-2. Overseas net production reached 185.1 million BOE, an increase of 4.3% YoY, which was mainly attributable to the production contribution from projects in Guyana and Brazil, among others.

For exploration, the Company made 5 new discoveries and successfully appraised 23 oil and gas-bearing structures in the first three quarters. Among them, Bozhong 8-3 South and Huizhou 21-8 continued to expand their reserve scale and are expected to become large and medium-sized oil and gas fields. For development and production, 9 new projects commenced production in the first three quarters. Bozhong 26-6 Oilfield continued to expand production capacity, effectively bolstering energy supply capacity in the Beijing-Tianjin-Hebei and Bohai Rim regions. Panyu 10-4 Oilfield achieved fully automated operations through intelligent systems and significantly reduced carbon dioxide emissions by applying a power generation system that recovers waste heat from produced water.

In the first three quarters of 2026, the Company's unaudited oil and gas sales revenue reached RMB 3,053.5 hundred million, an increase of 19.5% YoY. Net profit attributable to equity shareholders of the Company reached RMB 1,191.2 hundred million, an increase of 16.8% YoY. The Company's capital expenditures amounted to approximately RMB 899 hundred million, all implemented as planned. During the period, the Company's safety and environmental performance remained generally stable and under control.

Mr. Huang Yongzhang, Vice Chairman, Chief Executive Officer and President of the Company, said, "In the first three quarters, CNOOC Limited continued to pursue reserves and production growth and quality and efficiency enhancement, achieved steady growth in oil and gas production, and maintained its cost competitiveness. In the fourth quarter, we will focus on our annual targets, step up efforts in oil and gas exploration and development, and strengthen cost reduction, efficiency enhancement and lean management, to ensure the high-quality completion of the annual production and business operation tasks and make a good start to the 15th Five-Year Plan period."

â End â

Notes to Editors:

More information about the Company is available at https://www.cnoocltd.com.

*** *** *** ***

This press release includes forward-looking information, including statements regarding the likely future developments in the business of the Company and its subsidiaries, such as expected future events, business prospects or financial results. The words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company as of this date in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate under the circumstances. However, whether actual results and developments will meet the current expectations and predictions of the Company is uncertain. Actual results, performance and financial condition may differ materially from the Company's expectations, as a result of salient factors including but not limited to those associated with macro-political and economic factors, fluctuations in crude oil and natural gas prices, the highly competitive nature of the oil and natural gas industry, climate change and environment policies, the Company's price forecast, mergers, acquisitions and divestments activities, "health, safety, security and environment" (HSSE) and insurance policies and changes in anti-corruption, anti-fraud, anti-money laundering and corporate governance laws.

Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations.

*** *** *** ***

For further enquiries, please contact:

Zhang Feihu 

CNOOC Limited

Tel: +86-10-8452-1421

E-mail: [email protected]

Cheng Yao

Ever Bloom (HK) Communications Consultants Group Limited

Tel: +852 5540 0725

E-mail:[email protected]

SOURCE CNOOC Limited

Share this article